Supplemental oxygen is a life-saving intervention administered to individuals suffering from respiratory distress, including adults with acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Despite the clinical benefit, supplemental oxygen can create a hyperoxic environment that increases reactive oxygen species, oxidative stress, and lung injury. We have previously shown that cytochrome P450 (CYP)1A enzymes decrease susceptibility to hyperoxia-induced lung injury. In this investigation, we determined the role of CYP1B1 in hyperoxic lung injury in vivo. Eight-to ten-week old C57BL/6 wild type (WT) and Cyp1b1 À/À mice were exposed to hyperoxia (>95% O 2 ) for 24-72 h or maintained in room air (21% O 2 ). Lung injury was assessed by histology and lung weight to body weight (LW/BW) ratios. Extent of inflammation was determined by assessing pulmonary neutrophil infiltration and cytokine levels. Lipid peroxidation markers were quantified by gas chromatography mass spectrometry, and oxidative DNA adducts were quantified by 32 P-postlabeling as markers of oxidative stress. We found that Cyp1b1 À/À mice displayed attenuation of lung weight and pulmonary edema, particularly after 48-72 h of hyperoxia compared with WT controls. Further, Cyp1b1 À/À mice displayed decreased levels of pulmonary oxidative DNA adducts and pulmonary isofurans after 24 h of hyperoxia. Cyp1b1 À/À mice also showed increased pulmonary CYP1A1 and 1A2 and mRNA expression. In summary, our results support the hypothesis that Cyp1b1 À/À mice display decreased hyperoxic lung injury than wild type counterparts and that CYP1B1 may act as a pro-oxidant during hyperoxia exposure, contributing to increases in oxidative DNA damage and accumulation of lipid hydroperoxides.
ARDS incidence and mortality have focused on improving patient care practices, such as reducing tidal volume during mechanical ventilation (Acute Respiratory Distress Syndrome et al., 2000; Li et al., 2011; Villar et al., 2011) . Despite the use of protective ventilation strategies, ARDS mortality rates remain high, with reported mortality rates between approximately 35% and 50% (Villar et al., 2014) . These reports indicate that current treatment options for ALI/ARDS are supportive and there is a need for targeted therapies or treatment strategies to prevent and/or treat ALI/ARDS.
Animal models have shown that exposure to supraphysiological concentrations of oxygen create hyperoxic conditions which in turn leads to lung injury (Frank et al., 1978; Freeman and Crapo, 1981) . The longstanding hypothesis has been that the hyperoxic environment generates excess reactive oxygen species (ROS) leading to oxidative stress, which in turn promotes lung injury (Freeman and Crapo, 1981; Kallet and Matthay, 2013; Turrens et al., 1982) . Due to the perceived risk of hyperoxia as a contributor to lung injury, critical care physicians must determine optimum ventilation conditions to minimize the potential for hyperoxia-induced pulmonary toxicity (Mikkelsen et al., 2014) . Therefore, investigating the molecular mechanisms underlying hyperoxia toxicity may have therapeutic benefit for ARDS patients.
Many molecular pathways are associated with oxidative stress and ROS production, including cytochrome P450 (CYP) enzymes (White and Coon, 1980) . ROS, and in particular H 2 O 2 , can be generated by CYP enzymes during their reaction cycle through a process known as reaction uncoupling (Zangar et al., 2004) . Several reports detail that CYP enzymes, and specifically pulmonary CYP1A1 and hepatic CYP1A2, can be induced by hyperoxia (Gonder et al., 1985; Okamoto et al., 1993) . Studies from our laboratory group have shown that CYP1A enzymes may protect against oxidative stress and pulmonary injury due to hyperoxia exposure (Lingappan et al., 2014; Wang et al., 2015) . We have found that CYP1A-mediated metabolism of ROS generated lipid hydroperoxides, such as F 2 -isoprostanes, may play a mechanistic role in decreasing hyperoxia-induced lung injury . This would strongly suggest that CYP1A enzymes do not contribute to hyperoxic lung injury, but in fact protect against hyperoxic toxicity.
Although our laboratory has extensively investigated the role of CYP1A in hyperoxic toxicity, little is known about the potential role of CYP1B1, the third member of the CYP1 family, in hyperoxic toxicity. CYP1B1 shares 41% sequence homology with CYP1A1 and 38% homology with CYP1A2 . All 3 members of the CYP1 family are also transcriptionally regulated by the aryl hydrocarbon receptor (AHR) . AHR is a ligand-dependent transcription factors that recognizes dioxin response elements in promoter sequences and promotes transcription of its target genes, including CYP1A1 (Nebert et al., 1993) . Previous work in our laboratory has shown that CYP1A1, CYP1A2, and AHR knockout mouse models all have increased susceptibility to hyperoxia-induced lung injury (Jiang et al., 2004; Lingappan et al., 2014; Maturu et al., 2017; Wang et al., 2015) . Further, pharmacological induction of CYP1A, through AHR, can decrease susceptibility to hyperoxia (Couroucli et al., 2002 Shivanna et al., 2011; Sinha et al., 2005) . Despite the regulation and sequence similarities between CYP1A and CYP1B1, we have recently found that CYP1B1 may have an alternative role during hyperoxic exposure, and in fact, contributes to hyperoxic toxicity in a human cell culture model (Dinu et al., 2016) . This observation has led to this study, in which we investigated the role of CYP1B1 in a mouse model of hyperoxic toxicity, utilizing CYP1B1 knockout (Cyp1b1 À/À ) mice and highlighting any differences between Cyp1b1 À/À mice and the previously described Cyp1a1 À/À and Cyp1a2 À/À animal studies.
CYP1B1 is the subject of ongoing investigation in numerous biological and disease processes, as it is broadly expressed in both human and murine tissues, including the lungs (Choudhary et al., 2005) . CYP1B1 currently being studied for its role in a wide range of biochemical and disease processes, including lipid metabolism, glaucoma, and metabolism of PAHs (Buters et al., 1999; Gajjar et al., 2012; Larsen et al., 2015 Larsen et al., , 2016 Libby et al., 2003) . Some of these studies have examined the redox role of CYP1B1 and found that CYP1B1 suppresses ROS production and oxidative stress levels in endothelial cells and pericytes under high oxygen levels (Palenski et al., 2013a,b; Tang et al., 2010) . CYP1B1 has also been shown to elicit a biological effect through its metabolic activity in other models (Jennings et al., 2014; PingiLi et al., 2015) . Based on our in vitro studies in human lung cells, wherein CYP1B1 acts as a pro-oxidant, in this investigation, we tested the hypothesis that Cyp1b1 À/À mice will be less susceptible to hyperoxic lung injury unlike mice lacking CYP1A, and that Cyp1b1 À/À mice would display decreased accumulation of lipid hydroperoxides and oxidative DNA lesions during hyperoxia exposure. mouse line, on a C57BL/6J background, was generated by Dr. Frank J. Gonzalez and has been previously described in Buters et al. (1999) . Animals were maintained at the Feigin Center animal facility of Baylor College of Medicine (Houston, Texas). Animals were kept under a 12-h day/night light cycle and were provided purified tap water and food (Purina Rodent Lab Chow 5001 from Purina Mills, Inc., Richmond, Indiana) ad libitum. Mice used in these experiments were between 8-and 10-weeks old. Hyperoxic conditions were achieved by constant delivery of 100% oxygen into a sealed Plexiglas chamber and oxygen levels were monitored daily through oxygen analyzers.
MATERIALS AND METHODS
Hyperoxia exposure and tissue harvesting. Male WT and Cyp1b1 À/À mice were randomly selected for each treatment group and were maintained in room air (21% O 2 ), as a control group, or exposed to hyperoxia (>95% O 2 ) for up to 72 h or in room air. Following hyperoxia exposure, animals were anesthetized with sodium pentobarbital (200 mg/kg i.p.) and euthanized by exsanguination while under deep anesthetization. Lung and liver tissues were collected after 24, 48, and 72 h of hyperoxia with a room air control group. Mice were harvested in multiple cohorts, for pathological analysis, oxidative DNA 32 P-postlabeling, and for mRNA and protein analysis. Male and female mice were used in the lipid peroxidation and oxidative DNA adduct assays. Lung and liver tissues were collected and snap frozen À80 C for future analysis. However, in the pathological analysis cohort, lung tissues lung tissues were inflated with zinc formalin under constant pressure and, were processed for histological analysis.
Lung injury quantification. Lung weight and body weight changes during hyperoxia exposure were used to calculate lung weight to body weight ratios (LW/BW). This ratio was used as an index for changes in pulmonary edema and lung injury during hyperoxia exposure. Lung injury was also visualized by hematoxylin and eosin (H&E) staining. Neutrophils were detected immunohistochemically (IHC) by using Ly-6B.2 monoclonal antibody. Semiquantitative lung injury scoring was performed (with modifications) from the American Thoracic Society Workshop report on determining experimental ALI in animal models (MatuteBello et al., 2011) . This scoring system weighs several parameters of lung injury: number of neutrophils in the alveolar space, number of neutrophils in the interstitial space, presence of hyaline membranes, presence of proteinaceous debris filling the airspaces, and alveolar septal thickening (Matute-Bello et al., 2011) . The slides were evaluated in a blinded fashion. Twenty random high-power (400Â) fields of view from the H&E stained slides were used to quantify hyaline membranes, proteinaceous debris, and alveolar septal thickening. We modified this scoring system to quantify neutrophils from IHC slides as opposed to H&E slides. Neutrophil levels were quantified from twenty random high-power (400Â) fields of view from the IHC stained slides, as opposed to H&E slides. Neutrophils were quantified by averaging the number of Ly-6B.2 positive cells from 20 highmagnification (400Â) fields of view. Lower magnification fields of view are provided in Figures 1 and 3 to give a more holistic understanding of lung injury, encompassing the perivascular regions, large airways, and alveolar regions.
Cytokine array. A MILLIPLEX Multiplex assay (EMD Millipore, Billerica, Massachusetts) was performed to quantify various cytokine protein levels and assess inflammation. Frozen lung samples were added to a lysis buffer (1 ml) that was made from phosphate buffered saline and complete protease inhibitor cocktail (Roche Diagnostics, Indianapolis, Indiana) as previously described in Lingappan et al. (2013) . The following cytokines were assayed in our array: interlukin-6 (IL)-6, IL-10, vascular endothelial growth factor (VEGF), IL-1a, IL-1b, leukemia inhibitory factor (LIF), monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1-alpha (MIP-1a), and macrophage inflammatory protein 2 (MIP-2). Cytokines with levels outside of the observable range were labeled as not determined (N.D.) in figures.
RNA isolation and RT-PCR. Portions of the frozen lung and liver tissues were subjected to RNA isolation via Direct-zol RNA MiniPrep (Zymo Research, Irvine, California). Quantitative RT-PCR (qRT-PCR) was performed to quantitate mRNA of various target genes. Total liver and lung RNA (10-60 ng) were subjected to 1-step quantitative TaqMan qPCR. Applied Biosystems PRISM 7700 sequence detection system was used for RT-PCR experiments. The 18S gene was used as a reference gene in these analyses. Cycle threshold number (C t ) was used to obtain quantitative values for target and reference genes. The 2 ÀDDCt method was used to calculate the relative expression level of various target genes. All RT-PCR data were also normalized to WT room air controls. Primer List: Cyp1a1: Mm00487217_m1, Cyp1a2: Mm00487224_m1, Cyp1b1: Mm01232239, and Nqo1: Mm01253562 (All ThermoFisher Scientific TaqMan gene expression assays).
Microsome isolation. Due to the cellular localization of CYP enzymes in the endoplasmic reticulum, microsomes were extracted from lung and liver tissues to determine CYP1A/1B1 enzymatic activities and/or protein contents. Lung microsomes were isolated by differential centrifugation (Matsubara et al., 1974) and liver microsomes were isolated by calcium chloride precipitation, as previously described in Cinti et al. (1972) . Western blotting. Western blot was used to semiquantitatively measure protein levels. Lung and liver microsomal protein (5-10 lg protein) were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis in 8% or 10% acrylamide gels. Gels were then transferred to polyvinylidene difluoride membranes (PVDF) membranes. Membranes were blocked for 1 h in 5% milk and then incubated with primary antibody overnight at 4 C. CYP1A1 and CYP1A2 were blotted by a mouse CYP1A1 monoclonal antibody that cross-reacts with CYP1A2 (1:2000). CYP1B1 was blotted with a rabbit antibody was used against CYP1B1 (1:5000). HRP tagged antimouse, antirabbit, and antigoat secondary antibodies were incubated for 1 h at room temperature (1:2000-1:20,000). Blots were quantified with a BioRad ChemiDoc Touch and Image Lab software (BioRad Laboratories).
Lipid peroxidation. Levels of pulmonary isofurans and F 2 -isoprostanes in the lung were determined by gas chromatography mass spectrometry (GC-MS) in the laboratory of L. Jackson Roberts, as previously described in Fessel et al. (2002) . Briefly, as described in the Fessel et al., manuscript, F 2 -isoprostanes and isofurans levels were determined by comparison of the corresponding mass to charge ratios (m/z) of 569 and 585, respectively, to that of an internal standard. A detailed description of the methods used to isolate lipid peroxidation products has been previously described in Morrow and Roberts (1999) .
Oxidative DNA damage. 32 P-postlabeling was performed to quantify bulky oxidative DNA adduct formation during hyperoxia exposure. The postlabeling analyses were performed as described previously in Zhou and Moorthy (2015) . Briefly, DNA was isolated from lung tissue following hyperoxia exposure. The DNA was then subjected to micrococcal nuclease digestion. Cycloadenosine adducts were enriched by digestion with nuclease P1. Following digestion, nucleotides were labeled with [c-32 P]ATP. The labeled nucleotides were chromatographed on polyethyleneimine-impregnated cellulose thin layer chromatography (TLC) plates, and imaged by an Instant Imager (Packard Instruments, Merien, Connecticut). Levels of total 8,5
0 -cyclo-2 0 -deoxyadenosine (cA) oxidative DNA adducts, as well as the individual dinucleotides adenine cA (AcA), guanine cA (GcA), cytosine cA (GcA) and thymine cA (TcA) were analyzed as reported previously in Lingappan et al. (2017) and Zhou and Moorthy (2015) .
Statistical analysis. Data are expressed as means þ SEM. SEM was used to provide an estimate of the true mean. Two-way analysis of variances (ANOVA) was used to test significant differences in genotype and hyperoxia exposure as well as significant interactions between genotype and hyperoxia on each dependent variable. If the ANOVA analysis found any significant effects in the dataset, further statistical interrogation was performed. A Dunnett correction was applied to correct for multiple comparisons between room air controls and the various hyperoxia time points. Comparisons between genotype were made by independent samples t test. The pvalues < .05 were considered significant. Statistical analysis and figure generation was performed using GraphPad Prism version 7 (GraphPad Software, San Diego, California).
RESULTS
Hyperoxia-Induced Lung Injury Is Attenuated in Cyp1b1 2/2 Mice Compared With WT To assess lung injury in Cyp1b1 À/À and WT mice, we utilized histological sections and LW/BW ratios of mice exposed to hyperoxia with room air controls. Our group has previously shown that lung injury, and particularly pulmonary edema, increases during hyperoxia exposure (Jiang et al., 2004; Lingappan et al., 2014; Wang et al., 2015) which can be visualized as proteinaceous debris in the airways and quantitated by changes in lung weight. Lung injury and pulmonary edema are clearly evident after 72 h of hyperoxia ( Figure 1D ) and to a lesser extent after 48 h of hyperoxia ( Figure 1C ). However, evidence of pulmonary edema and lung injury were attenuated in the lungs of Cyp1b1 À/À mice after 48-72 h of hyperoxia (Figs. 1G-F).
Utilizing semiquantitative lung injury scoring, we found that Cyp1b1 À/À mice have significantly lesser lung injury after 48 h of hyperoxia ( Figure 1I ). Despite the general decrease in histological evidence of edema in Cyp1b1 À/À mice after 72 h of hyperoxia, there was not a significant difference in lung injury between WT and Cyp1b1 À/À mice after 72 h. However, breaking down the various scoring parameters, we found that Cyp1b1 À/À mice have an approximately 42% lower score in relation to proteinaceous debris in the airway after 72 h of hyperoxia (P ¼ 0.07; Supplementary Figure 1) . We also used LW/BW ratios in Cyp1b1 À/À and WT mice to assess lung injury ( Figure 2A ). Unexpectedly, Cyp1b1 À/À mice have significantly higher LW/BW ratios under the room air control conditions. This prompted us to examine the changes in LW/BW ratios from genotype-matched room air controls ( Figure 2B ) as well as lung weight and body weight individually (Figs. 2C-F). Here we clearly see that lung weights were lower in Cyp1b1 À/À mice compared with WT, particularly after 48-72 h hyperoxia. There was an increase of 45.7% and 141.3% in LW/BW in WT mice after 48-72 h, respectively; however, this effect was attenuated in Cyp1b1
mice (an increase of 22.8% and 71.5%, respectively). This effect was also observed, to a more pronounced degree, in female mice (Supplementary Figure 2) . This would support our histological evidence for decreased lung injury, predominately due to decreased pulmonary edema, in Cyp1b1 À/À mice compared with WT.
Lung weight and body weight measurements individually showed that lung weight was lower in Cyp1b1 Figure 1I ). Further, we independently quantified the number of positively stained cells in 20 random high magnification (400Â) fields ( Figure 3I ). We have previously observed that neutrophil levels in WT mice exhibit a biphasic response, with an initial increase neutrophils after 24 h of hyperoxia which decreases at 48 h and we see a trend supporting this (Figs. 3B and 3C ). We also observed lower neutrophils levels after 48 h of hyperoxia compared with WT. Qualitatively, we observed a possible localization of neutrophils near the larger airways in WT mice that was largely absent in Cyp1b1 À/À mice after 48 h (Figs. 3C and 3G ). This would suggest that there are changes in the neutrophil recruitment and response kinetics between WT and Cyp1b1 À/À mice. expected, hyperoxia had a significant effect on all of the cytokines tested. We quantified proinflammatory cytokines, such as IL-6, to determine if decreased proinflammatory cytokines could explain the attenuated injury observed in Cyp1b1 À/À mice.
Pulmonary IL-6 levels were induced by hyperoxia in both WT Cyp1b1 À/À mice, albeit at different rates. We found that WT mice
had an approximately 17-fold induction of IL-6 levels after 72 h while Cyp1b1 À/À mice displayed an approximately 8-fold induction ( Figure 4A ). We also wanted to determine if the attenuated injury phenotype of Cyp1b1 À/À mice could be explained with an increase in antiinflammatory cytokines, such as IL-10. Pulmonary IL-10 levels were decreased in both WT and Cyp1b1 À/À mice during hyperoxia ( Figure 4B ). Interestingly, we also found a genotype specific effect on VEGF levels (p ¼ .047). As shown in Figure 4C , Cyp1b1 À/À mice had approximately 52% higher levels of pulmonary VEGF protein compared with WT mice following 24 h of hyperoxia. This suggests that increased early VEGF levels may play a role in the phenotype of Cyp1b1 À/À mice to hyperoxia exposure. The results from the other cytokines tested in this experiment can be found in Supplementary Figure 3 .
Hyperoxia Induces Cyp1b1 Gene Expression in the Lung
We have previously shown that hyperoxia is sufficient to induce pulmonary CYP1A1 and hepatic CYP1A2 (Lingappan et al., 2014; Wang et al., 2015) . However, no study to our knowledge has quantified pulmonary CYP1B1 levels during hyperoxia exposure. CYP1B1 is expressed in extrahepatic tissues, including the lung, and can be induced by numerous xenobiotics (Choudhary et al., 2005; . We used qPCR and Western blot to quantify CYP1B1 gene expression and protein levels ( Figure 5 ). As seen in Figure 5A , CYP1B1 gene expression is induced by hyperoxia at all time points (between 1-and 5-fold) compared with room air in WT mice. As expected, CYP1B1 gene expression was significantly decreased in the Cyp1b1 À/À mice at all time points. Despite the robust change in CYP1B1 gene expression, there was not see a similar trend in CYP1B1 protein levels (Figs. 5B and 5C). There was also no induction of hepatic CYP1B1 gene expression by hyperoxia (data not shown). Figure 6 ). In WT mice, CYP1A1 gene expression was increased after 24 h of hyperoxia with a subsequent decrease in expression after 48-72 h of hyperoxia ( Figure 6A ), similar to previous studies in our laboratory. Cyp1b1 À/À mice, on the other hand, showed significantly increased pulmonary CYP1A1 gene expression throughout hyperoxia exposure, ranging from approximately a 1.2-fold increase after 24 h to 2.3-fold increase after 48 h hyperoxia ( Figure 6A ), as compared with room air controls. CYP1A protein levels were induced in both WT (5.5-fold) and Cyp1b1 À/À (4.8-fold) mice after 72 h hyperoxia (Figs. 6B and 6C).
Cyp1a Gene Expression is Higher in
Analysis of hepatic CYP1A2 gene expression revealed more subtle changes ( Figure 6D ). There was a modest induction of CYP1A2 gene expression after 24 h of hyperoxia in WT mice, similar to pulmonary CYP1A1 that decreases after 48-72 h of hyperoxia. There were higher levels of hepatic CYP1A2 gene expression in Cyp1b1 À/À mice compared with WT mice after 48 h of hyperoxia. While CYP1A2 gene expression is markedly decreased after 48 h of hyperoxia compared with room air while Cyp1b1 À/À mice maintain approximately 95% of CYP1A2 gene expression observed in room air. Unlike pulmonary CYP1A1, hepatic CYP1A2 protein levels remained relatively constant throughout the experiment in both genotypes. Significant differences between WT and Cyp1b1 À/À mice at each time point are indicated by *p < .05, **p < .01, and ***p < .001. Significant differences between WT and Cyp1b1 À/À mice at each time point are indicated by *p < .05, **p < .01, and ***p < .001. Significant differences between room air control animals and hyperoxia exposed animals within each genotype are indicated by # p < .05, ## p < .01, and ### p < .001.
Hyperoxia Induces Nrf2-Dependent Gene Expression in Both WT and Cyp1b1 2/2 Mice Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is known as a master transcriptional regulator of the oxidative stress response and antioxidant gene expression, including NQO1 (Ma, 2013) . We analyzed pulmonary and hepatic NQO1 gene expression as a surrogate for Nrf2-dependent transcription. Pulmonary NQO1 gene expression is induced by hyperoxia and persists throughout hyperoxia exposure in both WT and Cyp1b1 À/À mice ( Figure 7A ). Hepatic NQO1 gene expression was also induced by hyperoxia, but in contrast to pulmonary NQO1 gene expression, was a gradual induction ( Figure 7B ). This would suggest that Nrf2-dependent transcription is induced by hyperoxia and is similar between WT and Cyp1b1 À/À mice.
Cyp1b1

2/2 Mice Showed Decreased Pulmonary Isofurans Compared
With WT Mice Exposed to Hyperoxia Excess ROS production has been hypothesized to be a major contributor to hyperoxic toxicity, leading to increases in oxidative stress and cellular damage. We used GC-MS was used to quantify pulmonary lipid peroxidation markers as an index of oxidative stress and ROS levels ( Figure 8 ). We found that Cyp1b1 À/À mice had approximately 40% lesser levels of pulmonary isofurans after 24 h of hyperoxia compared with WT mice. However, we did not observe any significant differences in pulmonary F 2 -isoprostanes levels between WT and Cyp1b1 À/À mice.
Cyp1b1
2/2 Mice Have Decreased Pulmonary Oxidative DNA Adducts During Hyperoxia Exposure Compared With WT Controls ROS production can also lead to oxidative DNA damage. Oxidative DNA damage was assessed by 32 P-postlabeling. The oxidative adduct(s) of interest in this experiment were purine dinucleotides containing 8, 5'-cyclo-2'-deoxyadenosine (cA), including AcA, CcA, GcA, and TcA adducts. The cA adducts are formed by hydroxyl radical attack on 2'-deoxyadenosine which then results in a covalent bond with the adjacent nucleotide Zhou and Moorthy, 2015) . The location of these adducts in the TLC plates was based on cochromatography and rechromatography using structurally characterized standards ( Figure 9A ). Total pulmonary adducts were quantified in Figure 9B , which included the aggregate values of AcA, CcA, GcA, and TcA adducts. The individual dinucleotide adducts were also analyzed as well (Figs. 9C-F).
We found that levels of total oxidative DNA adducts were increased in WT mice during hyperoxia exposure ( Figure 8B ). However, we found that total oxidative DNA adduct formation during hyperoxia exposure was dependent on genotype (p < .001). Hyperoxia increased oxidative DNA adduct levels in WT mice, with the highest levels seen after 72 h hyperoxia (1.4-fold increase). Interestingly, we found that total oxidative DNA adducts were significantly increased (1.8-fold) in Cyp1b1 À/À mice at room air. Further, these adduct levels decrease significantly during hyperoxia exposure, as seen by a 77% decrease in adduct levels after only 24 h.
Each of the dinucleotide adducts were also analyzed individually (Figs. 9C-F) . TcA adducts were the most abundant adduct and therefore had a similar pattern to the total oxidative DNA adducts ( Figure 9F ). Similar to the total adducts, 2-way ANOVA identified a significant interaction (p < .001) between genotype and hyperoxia exposure in TcA adduct formation, again suggesting that formation of TcA adducts by hyperoxia is dependent on genotype. As seen with the total adducts, Cyp1b1 À/À mice had higher adduct levels in room air compared with WT controls, and the levels sharply decreased under hyperoxic conditions. The other 3 dinucleotide adducts were present at lower levels. CcA adducts were the second most abundant adduct and had a different pattern than that of TcA adducts in both WT and Cyp1b1 À/À mice ( Figure 9D ). Most notably, hyperoxia induced the formation of CcA adducts in WT only, and that there was no difference in adduct levels between WT and Cyp1b1 À/À mice at room air. We found that neither hyperoxia nor genotype exerted a major effect on GcA nor AcA adducts (Figs. 9E and 9F ).
DISCUSSION
The major goal of this study was to determine if CYP1B1 played a similar role as CYP1A in hyperoxic toxicity in vivo. We found evidence that Cyp1b1 À/À mice have decreased lung injury and pulmonary edema during hyperoxia exposure when compared with WT mice, corroborating findings from our previous study which suggested that CYP1B1 can contribute to hyperoxic toxicity in cells (Dinu et al., 2016) . We found histological evidence for decreased edema in Cyp1b1 À/À mice exposed to hyperoxia compared with WT mice (Figure 1 and Supplementary Figure 1) .
We observed a decreased rate of change in LW/BW ratios and lung weight in Cyp1b1 À/À mice compared with WT in both male ( Figure 2 ) and female mice (Supplementary Figure 2) . Importantly, we found that the change in LW/BW ratios was due to genotype-dependent changes in lung weight during hyperoxia exposure (Figure 2 ). This was in stark contrast to our previous work in which we found that Cyp1a1 À/À and Cyp1a2
are more susceptible to hyperoxic lung injury, evident by increased LW/BW ratios and evidence of pulmonary edema (Lingappan et al., 2014; Wang et al., 2015) . Further, we found that markers of oxidative stress, including lipid peroxidation products and oxidative DNA damage were decreased in Cyp1b1 À/À mice exposed to hyperoxia when compared with WT, suggesting decreased levels of ROS-mediated pulmonary injury. The decreased evidence of hyperoxic toxicity supports the hypothesis that CYP1B1 may contribute to hyperoxia and ROS-mediated pulmonary injury. In this study, we also quantified neutrophils as a measure of lung injury and the inflammatory response. We found that neutrophil levels are rapidly decreased in Cyp1b1 À/À mice during hyperoxia exposure, suggesting that CYP1B1 may play a role in early hyperoxia neutrophil recruitment (Figure 2 ). The fact that there were no differences in neutrophils levels between WT and Cyp1b1 À/À mice at the 72 h time point is not clearly understood.
Previous studies from our laboratory have found that neutrophil recruitment to the lung increases after 24 h hyperoxia, then decreases after 48 h, and increases again after 72 h, and that neutrophil levels are significantly higher in Cyp1a1 À/À and Cyp1a2 À/À mice after 24 and 72 h hyperoxia (Lingappan et al., 2014; Wang et al., 2015) . Although a similar pattern was observed in WT mice in this study, it was noticeably absent in Cyp1b1 À/À mice. This suggests that changes in the acute stages of injury in Cyp1b1 À/À mice, possibly including the inflammatory response, may contribute to the decreased lung injury after 48-72 h of hyperoxia. IL-6 has previously been shown to increase with lung injury and were increased in Cyp1a1 À/À mice and Cyp1a2 À/À mice, correlating with increased lung injury (Lingappan et al., 2014; Wang et al., 2015) . Unexpectedly, we found similar levels of IL-6 between WT and Cyp1b1 À/À mice. This was in contrast with the Cyp1a1 À/À and Cyp1a2 À/À mouse models, in which pulmonary IL-6 is significantly increased in the knockout mice. We also sought to determine if the attenuated injury in Cyp1b1 À/À mice was associated with an increase in anti-inflammatory cytokines, such as IL-10. IL-10 has previously been shown to protect against hyperoxic lung injury . However, as seen in Figure 4B , IL-10 levels decrease in both WT and Cyp1b1 À/À mice. Although there were few differences in the other cytokines tested in our array, changes in VEGF levels did stand out. Although the role of VEGF in hyperoxic lung injury is unclear, emerging evidence suggests that VEGF may play a vital role in pulmonary disease, possibly through endothelial cell Toll-like receptor 4 (TLR4)-VEGFR signaling and/or bronchial epithelial cell secretion of VEGF (Takyar et al., 2016; Tsai et al., 2015) . This raises the possibility that increased VEGF expression in Cyp1b1 À/À mice may contribute to the attenuation of lung injury. Future experiments will be needed to fully elucidate any mechanistic role early VEGF has in hyperoxic toxicity and any connection between CYP1B1 and VEGF expression.
Although our group has focused on CYP1A expression during hyperoxia exposure, little is known regarding CYP1B1 expression. Due to CYP1B1 sharing a common transcription regulation mechanism as CYP1A in the AHR, we anticipated that CYP1A and CYP1B1 would have a similar gene expression profile. However, we found that CYP1B1 gene expression differs significantly from CYP1A. Although CYP1A gene expression increases initially (Figure 6 ), CYP1B1 expression is induced throughout hyperoxia exposure ( Figure 5 ). This may be due to differences in cell-specific expression of CYP1B1 and CYP1A1 and is the subject of ongoing experiments. Also, unexpectedly, we found that CYP1B1 protein levels remained constant during hyperoxia exposure, despite the robust changes in gene expression. This could have been due to the complex translational regulation governing CYP1B1 proteins levels, including an upstream open reading frame and a microRNA binding region in the 3 0 untranslated region (UTR) (Chuturgoon et al., 2014; Devlin et al., 2010) . Thus, it is possible CYP1B1 protein levels may be tightly regulated, especially under hyperoxic conditions, and may explain the discordance between mRNA and protein levels. Further, this suggests that even low levels of CYP1B1 protein can contribute to hyperoxic toxicity. ROS can act pathogenically through the modification of nucleic acids, proteins, and lipids and are the likely mediators of hyperoxic toxicity (Sies et al., 2017) . We have previously shown that F 2 -isoprostanes, a lipid peroxidation product, are induced by hyperoxia and can be detoxified by CYP1A enzymes (Maturu et al., 2017; Wang et al., 2015) . We found that pulmonary F 2 -isoprostane levels were similar between Cyp1b1 À/À and WT mice ( Figure 8B ). However, we did find that pulmonary isofuran levels were decreased in Cyp1b1 À/À mice compared with WT mice after 24 h of hyperoxia ( Figure 8A ). Interestingly, isofurans are a lipid peroxidation product that is preferentially formed under high oxygen tensions (Fessel et al., 2002) . Our data suggests that CYP1B1 may have some role in the formation of pulmonary isofurans during hyperoxia exposure but not on F 2 -isoprostane levels. Further work will be needed to ascertain the biological role of isofurans in hyperoxic toxicity and the potential mechanism by which CYP1B1 contributes to their formation. Hyperoxia has been shown to induce DNA damage, including the formation of cA adducts, as our laboratory has recently found that both Cyp1a1 À/À and Cyp1a2 À/À mice have increased oxidative DNA adducts during hyperoxia exposure O'Reilly, 2001 ). This was expected, as increased oxidative DNA adducts would correlate with increased injury, and the CYP1 enzymes have previously been shown to be involved in the formation of xenobiotic DNA adducts, which can alter immune function (Galvan et al., 2006; Larsen et al., 2016) . As such, Cyp1b1 À/À mice had decreased oxidative DNA adducts compared with WT mice during hyperoxia exposure ( Figure 9 ). However, we were surprised to observe that oxidative DNA adducts were significantly higher in Cyp1b1 À/À mice compared with WT mice under room air conditions sharply decrease during hyperoxia exposure. This would strongly suggest that CYP1B1 plays a role in preventing and/or repairing these adducts under normal conditions. However, upon hyperoxia exposure, the role of CYP1B1 on oxidative DNA adducts formation changes and CYP1B1 appears to contribute to the increase in these adducts during hyperoxia exposure. This may be due to alterations in DNA repair in CYP1 knockout mice. These cA adducts are repaired by nucleotide excision repair (NER) (Zhou and Moorthy, 2015) . We have found that DNA repair is dysregulated in Cyp1a1 À/À and Cyp1a2 À/À mice exposed to hyperoxia . Future experiments utilizing discoverybased approaches will allow us to determine the effect of CYP1B1 on various DNA repair pathways, including NER, in both normal conditions as well as under hyperoxic conditions. Similar levels of NQO1 gene expression in both WT and Cyp1b1 À/À mice suggests that there are similar levels of Nrf2-dependent transcription. This would suggest that, despite decreased markers of oxidative stress in Cyp1b1 À/À mice, there are similar levels of ROS being produced in both WT and Cyp1b1
mice. This is because Nrf2 is bound by KEAP1 in the cytosol, until changes in cysteine residues permit a conformational change in Keap1, releasing Nrf2 and allowing Nrf2 to translocate to the nucleus and transcribe its target genes (Ma, 2013) . As expected, Nrf2 has previously been shown to be necessary to protect against hyperoxic toxicity (Reddy et al., 2009 may indirectly contribute to a pro-oxidant by indirectly regulating oxidative stress response, such as DNA repair, via its metabolic activity rather than directly increasing H 2 O 2 through reaction uncoupling. Tang et al. (2009) , previously showed that retinal endothelial cells from Cyp1b1 À/À mice exhibit increased oxidative stress. This highlights the importance of context in understanding any potential role of CYP1B1 on ROS and oxidative stress, as our data strongly supports a pro-oxidant role for CYP1B1 in hyperoxic lung injury. One possible way CYP1B1 could act as a pro-oxidant indirectly is through its metabolic activity. A well-established mechanism of AHR negative regulation by xenobiotics is CYP1-mediated metabolism of xenobiotics (Bersten et al., 2013) . We have previously shown that induction of CYP1A during hyperoxia exposure is through the canonical AHR pathway (Couroucli et al., 2002; Maturu et al., 2017) . In the present study, we found increased levels of CYP1A gene expression in Cyp1b1 À/À mice, which is likely due to increased AHR-dependent transcription. This provides a possible mechanism by which CYP1B1 could indirectly act as a pro-oxidant. AHR is known to play a major role in hyperoxic lung injury and regulate the expression of many gene pathways during hyperoxia exposure (Bhattacharya et al., 2014; Jiang et al., 2004; Shivanna et al., 2016) . Therefore, increased CYP1A gene expression in Cyp1b1 À/À mice may serve as an index for AHR-dependent transcription, which likely also induces other protective gene pathways. Although the mechanism by which AHR is induced during hyperoxia is unclear, there is a growing appreciation for the role endogenous AHR ligands have, including those that can be generated under oxidizing conditions (Chiaro et al., 2007; Smirnova et al., 2016) . The lack of change in CYP1A protein levels between WT and Cyp1b1 À/À mice suggests that the attenuated phenotype of Cyp1b1 À/À mice is independent of CYP1A. Recently we have found experimental evidence in support of this hypothesis, in that Cyp1a1 À/À /Cyp1a2 À/À /Cyp1b1 À/À knockout mice are also resistant to hyperoxic toxicity (Veith et al., unpublished data) . Future studies will be needed to determine the potential role and/or mechanism of CYP1B1-mediated regulation of AHRdependent transcription in our proposed model (Figure 10 ).
In conclusion, we have made the novel observation that, unlike CYP1A1/1A2, CYP1B1 possibly contributes to hyperoxic toxicity in vivo and that Cyp1b1 À/À mice have evidence of decreased lung injury during hyperoxia exposure. The results presented here suggest that Cyp1b1 À/À mice have a decelerated response to hyperoxic toxicity and that their injury response is delayed. This included decreased markers of oxidative stress in Cyp1b1 À/À mice after 24 h of hyperoxia exposure. These results are particularly interesting given that CYP1A1 and CYP1A2 appear to mitigate hyperoxic toxicity and that injury is accelerated in Cyp1a1 À/À and Cyp1a2 À/À mice. Subsequent experiments are needed to validate CYP1B1 as a viable therapeutic target to prevent and/or treat hyperoxic toxicity in ALI/ARDS. However, we believe that this is an initial step to determining the role of CYP1B1 in hyperoxic toxicity.
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